File(s) under permanent embargo
TrkB Receptor Agonist 7,8 Dihydroxyflavone is Protective Against the Inner Retinal Deficits Induced by Experimental Glaucoma
journal contribution
posted on 2022-05-01, 00:00 authored by V Gupta, N Chitranshi, Veer GuptaVeer Gupta, Y You, R Rajput, J A Paulo, M Mirzaei, M van den Buuse, S L GrahamTrkB Receptor Agonist 7,8 Dihydroxyflavone is Protective Against the Inner Retinal Deficits Induced by Experimental Glaucoma
History
Journal
NeuroscienceVolume
490Pagination
36 - 48Publisher
ElsevierLocation
Amsterdam, The NetherlandsPublisher DOI
ISSN
0306-4522eISSN
1873-7544Language
engPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Categories
No categories selectedKeywords
retinaglaucoma7,8 DHFretinal ganglion cellsTrkB receptoramyloidScience & TechnologyLife Sciences & BiomedicineNeurosciencesNeurosciences & NeurologyGANGLION-CELL SURVIVALMOUSE MODELALZHEIMERS-DISEASETHERAPEUTIC-EFFICACYNEUROTROPHIC FACTORMEMORY DEFICITSAMYLOID-BETAGENE-THERAPY7,8-DIHYDROXYFLAVONEBDNFamyloid β
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC